Dr. Ankit Mahadevia is a physician–entrepreneur and biotechnology executive with extensive experience in company formation, capital strategy, and clinical advancement. He currently serves as a CXO at Curie Bio, where he works closely with founding teams on corporate strategy, financing, and progression to human clinical trials.

Dr. Mahadevia has co-founded nine biotechnology companies, six of which were acquired in transactions collectively valued at more than $5 billion. Across companies he has led, advised, or supported, more than $1 billion in financing has been raised. He serves as a board member of Judo Bio and advises multiple early- and growth-stage life sciences companies. He earned a BA in economics and biology, summa cum laude, from Northwestern University, an MD from Johns Hopkins University School of Medicine, and an MBA in healthcare management from the Wharton School.